Alpa Laboratories Ltd
ALPAAlpa Laboratories Ltd
ALPA
Price Chart
Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 10.96 | 1.51 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.48 | 5.11 | 0.70% |
Forecast & Ratings
Detailed ForecastPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Alpa Laboratories Limited is a pharmaceutical company. The Company operates in the drugs and chemicals segment.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 60.18 | 58.77 | 68.59 | 67.71 | 83.29 | 88.88 | 101.95 | 123.05 | 102.33 | 123.70 | ||||||||||
Raw Materials | 35.18 | 31.86 | 35.79 | 35.93 | 47.31 | 51.42 | 60.62 | 69.24 | 53.67 | 100.25 | ||||||||||
| Power & Fuel Cost | 1.80 | 1.49 | 1.58 | 1.76 | 2.01 | 2.21 | 2.43 | 2.64 | 3.04 | |||||||||||
| Employee Cost | 7.63 | 7.20 | 8.67 | 10.26 | 12.04 | 11.82 | 11.75 | 11.93 | 12.17 | |||||||||||
| Selling & Administrative Expenses | 5.81 | 6.56 | 6.09 | 6.32 | 8.21 | 8.80 | 7.56 | 8.29 | 7.08 | |||||||||||
| Operating & Other expenses | 4.71 | -0.35 | 6.32 | 4.65 | 7.28 | 8.37 | 7.50 | 9.50 | 8.92 | |||||||||||
EBITDA | 5.05 | 12.01 | 10.14 | 8.79 | 6.44 | 6.26 | 12.09 | 21.45 | 17.45 | 23.45 | ||||||||||
| Depreciation/Amortization | 6.07 | 0.83 | 2.78 | 3.07 | 3.12 | 3.16 | 1.23 | 1.66 | 1.33 | 1.40 | ||||||||||
| PBIT | -1.02 | 11.18 | 7.36 | 5.72 | 3.32 | 3.10 | 10.86 | 19.79 | 16.12 | 22.05 | ||||||||||
| Interest & Other Items | 1.70 | 1.45 | 1.71 | 1.07 | 0.57 | 0.20 | 0.08 | 0.22 | 0.22 | 0.15 | ||||||||||
| PBT | -2.72 | 9.73 | 5.65 | 4.65 | 2.75 | 2.90 | 10.78 | 19.57 | 15.90 | 21.90 | ||||||||||
| Taxes & Other Items | -1.31 | 2.89 | 3.12 | 1.83 | 1.74 | 1.06 | 3.54 | 5.47 | 3.31 | 3.31 | ||||||||||
| Net Income | -1.41 | 6.84 | 2.53 | 2.82 | 1.01 | 1.84 | 7.24 | 14.10 | 12.59 | 18.59 | ||||||||||
| EPS | -0.67 | 3.25 | 1.20 | 1.34 | 0.48 | 0.87 | 3.44 | 6.70 | 5.98 | 8.84 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Alpa Laboratories Ltd | 16.19 | 1.51 | — |
| Sun Pharmaceutical Industries Ltd | 35.09 | 5.01 | 0.93% |
| Cipla Ltd | 35.23 | 4.16 | 0.69% |
| Dr Reddy's Laboratories Ltd | 21.37 | 4.14 | 0.69% |
Price Comparison
Compare ALPA with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Decreased Total Retail Holding
In last 3 months, retail holding in the company has decreased by 1.29%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
ALPA has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNews & Opinions
Alpa Laboratories Ltd leads losers in ‘B’ group
10 months ago•Business Standard
Globalspace Technologies Ltd leads losers in ‘B’ group
1 year ago•Business Standard
Alpa Laboratories Ltd leads gainers in ‘B’ group
2 years ago•Business Standard
Kaya Ltd leads gainers in ‘B’ group
2 years ago•Business Standard
Alpa Laboratories Ltd leads gainers in ‘B’ group
2 years ago•Business Standard
Alpa Laboratories standalone net profit rises 22.01% in the December 2020 quarter
2 years ago•Business Standard
Alpa Laboratories consolidated net profit rises 44.57% in the December 2020 quarter
2 years ago•Business Standard
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 8.61%, vs industry avg of 8.45%
Constant Market Share
Over the last 5 years, market share stayed at 0.03%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 34.88%, vs industry avg of 9.82%